MEK Inhibitor and Thoracic Radiotherapy Trial

NCT01146756 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: AZD6244

Sponsor

The Christie NHS Foundation Trust

Collaborators

[object Object]
[object Object]